DrugId:  1
1. Name:  Padimate O
2. Groups:  Approved
3. Description:  Padimate O is an organic compound related to the water-soluble compound PABA (4-aminobenzoic acid) that is used as an ingredient in some sunscreens. This yellowish water-insoluble oily liquid is an ester formed by the condensation of 2-ethylhexanol with dimethylaminobenzoic acid. Other names for padimate O include 2-ethylhexyl 4-dimethylaminobenzoate, Escalol 507, octyldimethyl PABA, and OD-PABA. Padimate provides skin protection against UV-B ray-induced skin damage by absorbing ultraviolet rays.
4. Indication:  Not Available
DrugId:  2
1. Name:  Petrolatum
2. Groups:  Approved, Investigational
3. Description:  A colloidal system of semisolid hydrocarbons obtained from petroleum. It is used as an ointment base, topical protectant, and lubricant.
4. Indication:  For use as an over the counter skin protectant [FDA Label]. Commonly used to treat diaper rash and chapped lips [FDA Label] [1].
DrugId:  3
1. Name:  Phenol
2. Groups:  Approved, Experimental
3. Description:  Phenol is an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. Phenol has been used to disinfect skin and to relieve itching. Phenol is also used as an oral analgesic or anesthetic in products such as Chloraseptic to treat pharyngitis. Additionally, phenol and its related compounds are used in surgical ingrown toenail treatment, a process termed phenolization. Research indicates that parental exposure to phenol and its related compounds are positively associated with spontaneous abortion. During the second world war, phenol injections were used as a means of execution by the Nazis. Phenol is a toxic compound whose vapours are corrosive to the skin, eyes, and respiratory tract. 
4. Indication:  Phenol is primarily indicated for minor sore throat pain, sore mouth, minor mouth irritation, and pain associated with canker sores. Additionally, phenol is indicated in the treatment of focal spasticity. 
DrugId:  4
1. Name:  Interleukin-10
2. Groups:  Investigational
3. Description:  Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis, Bile Duct Diseases, Pancreatic Diseases, and Gallbladder Diseases, among others.
4. Indication:  Not Available
DrugId:  5
1. Name:  L-Myo-Inositol-1-Phosphate
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  6
1. Name:  Oxybenzone
2. Groups:  Approved
3. Description:  Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone. It forms colorless crystals that are readily soluble in most organic solvents. It is used as an ingredient in sunscreen and other cosmetics because it absorbs UV-A ultraviolet rays.
4. Indication:  Used as an ingredient in sunscreen and other cosmetics.
DrugId:  7
1. Name:  NVS antibody
2. Groups:  Investigational
3. Description:  This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.
4. Indication:  Investigated for use/treatment in autoimmune diseases and rheumatoid arthritis.
DrugId:  8
1. Name:  Burlulipase
2. Groups:  Investigational
3. Description:  Burlulipase has been used in trials studying the treatment of Lung Diseases, Cystic Fibrosis, Pancreatic Insufficiency, Digestive System Diseases, and Respiratory Tract Diseases.
4. Indication:  Not Available
DrugId:  9
1. Name:  Methyl nicotinate
2. Groups:  Approved, Experimental
3. Description:  Methyl Nicotinate is a nicotinic acid methyl ester, used as rubefacient in cosmetics to produce a redness or inflammation for a short period of time, often in lip plumpers or other lip products. In the U.S. it is used in unapproved OTC formulations for the temporary relief of minor aches and pains of muscles and joints.
4. Indication:  Not Available
DrugId:  10
1. Name:  Octinoxate
2. Groups:  Approved, Investigational
3. Description:  Octinoxate is a cinnamate ester and common ingredient in sunscreen and other skin care products to minimize DNA photodamage. It was originally developed in 1950's as an organic UV-B filter that absorbs UV-B rays from sun. It is often combined with nanoparticles or other water-resistant liposomes in formulations to increase the localization at the epidermis and decrease the risk of percutaneous absorption. Its use in pharmaceutical and cosmetic formulations is approved by FDA.
4. Indication:  As an active ingredient in sunscreens and lip balms. Used for protection against damaging effects of sun rays. 
DrugId:  11
1. Name:  Dimethicone
2. Groups:  Approved
3. Description:  Dimethicone is a silicone oil that is also known as polydimethylsiloxane (PDMS). It has viscoelastic properties. Dimethicone is used as a surfactant, antifoaming agent, carminative in various products such as medical devices, food products, and lubricants. It is used in a number of health and beauty products including hair care products such as shampoo, conditioner, leave-in conditioner, and de-tangling products. On skin, it is also observed to have moisturizing actions [6, 8].A study found that that the 100 % dimethicone product is a safe and highly effective head lice treatment for children and may serve as less toxic and less resistance-prone alternative to pesticide-containing products [3].
4. Indication:  Dimethicone is a colorless liquid with both cosmetic and therapeutic uses. It is used in topical creams and ointments to help distribute the active ingredients. Dimethicone is used as an anti-foaming agent, a hair and skin conditioner, and in the treatment of head lice and, as an anti-bloating/anti-flatulence agent [2], [7].
DrugId:  12
1. Name:  Octisalate
2. Groups:  Approved
3. Description:  Also known as Ethylhexyl Salicylate. Octyl salicylate is an oil soluble chemical sunscreen agent that absorbs UVB radiation. It does not protect against UVA.Octyl salicylate is used to augment the UVB protection in a sunscreen. Salicylates are weak UVB absorbers and they are generally used in combination with other UV filters. Octyl salicylate appears to have a good safety profile.It covers wavelength in the range 295-315 nm, peak at 307-310 nm. It is an ester of salicylic acid and 2-ethylhexanol. The salicylate portion of the molecule absorbs ultraviolet light, protecting skin from the harmful effects of exposure to sunlight. The ethylhexanol portion is a fatty alcohol, adding emollient and oil-like (water resistant) properties
4. Indication:  Ingredient in sunscreens for protection against damage effects of sun light, provides protection from sunburns, aging and skin cancer. 
DrugId:  13
1. Name:  TRX1
2. Groups:  Investigational
3. Description:  TRX1 is a humanized antibody that binds to the CD4 receptor found on a subset of T cells. TRX1 is being developed for the potential treatment of autoimmune diseases in collaboration with Genentech, Inc. TolerRx is currently conducting a Phase I clinical study of TRX1 in the United Kingdom.
4. Indication:  Investigated for use/treatment in autoimmune diseases.
DrugId:  14
1. Name:  PN0621
2. Groups:  Investigational
3. Description:  PN0621 is an anti-TNF, domain antibody (dAb) based therapeutic. It targets tumour necrosis factor (TNF) to treat auto-immune inflammatory diseases such as rheumatoid arthritis. It is being developed by Peptech.
4. Indication:  Intended for the treatment of auto-immune diseases such as rheumatoid arthritis, psoriasis and Crohn's disease.
DrugId:  15
1. Name:  Lexaptepid Pegol
2. Groups:  Investigational
3. Description:  Lexaptepid Pegol has been used in trials studying the treatment of Anemia, Inflammation, Chronic Diseases, End Stage Renal Disease, and Anemia of Chronic Disease.
4. Indication:  Not Available
DrugId:  16
1. Name:  Camphor
2. Groups:  Approved
3. Description:  A bicyclic monoterpene ketone found widely in plants, especially cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent.
4. Indication:  Not Available
DrugId:  17
1. Name:  R1295
2. Groups:  Investigational
3. Description:  R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis. 
4. Indication:  Investigated for use/treatment in rheumatoid arthritis.
DrugId:  18
1. Name:  Polihexanide
2. Groups:  Approved, Investigational
3. Description:  Polihexanide has been used in trials studying the treatment, prevention, and supportive care of Caries, Neoplasm, Skin Diseases, Nail Diseases, and Dental Plaque, among others.
4. Indication:  Not Available
DrugId:  19
1. Name:  Octocrylene
2. Groups:  Approved, Investigational
3. Description:  Octocrylene is an organic compound used as an ingredient in sunscreens and cosmetics.
4. Indication:  In the US, Octocrylene has been evaluated by the FDA and is considered safe for use up to 10% in the formula. Similarly, the EU allows its use up to 10% in a formula while Health Canada allows a maximum use level of 12%. 
DrugId:  20
1. Name:  LX-2931
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in rheumatoid arthritis, inflammatory disorders (unspecified), and autoimmune diseases.
DrugId:  21
1. Name:  Avobenzone
2. Groups:  Approved, Investigational
3. Description:  Avobenzone is dibenzoyl methane derivative. It is oil soluble ingredient. Avobenzone has the ability to absorb ultraviolet light over wider range of wavelengths. It is included in many commercially available sunscreens which are used as wide spectrum sunscreens. Avobenzone is very sensitive to light, to increase its stability and duration of action, photostablizers are added in the sunscreen product. Avobenzone has an absorption maximum of 357 nm. Sunscreens containing avobenzone is indicated for providing protection from the sun. In addition to limiting the skin's exposure to the sun, using sunscreen agents may help reduce long-term sun damage such as premature aging of the skin and skin cancer.
4. Indication:  Sun protection factor, added in the sunscreen products for its wide spectrum ultraviolet absorption properties. 
DrugId:  22
1. Name:  KB002
2. Groups:  Investigational
3. Description:  KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
4. Indication:  Investigated for use/treatment in rheumatoid arthritis.
DrugId:  23
1. Name:  humanized SMART Anti-IL-12 Antibody
2. Groups:  Investigational
3. Description:  The humanized anti-IL-12 antibody is an important addition to PDL's already strong pipeline of humanized antibodies being developed for the treatment of autoimmune diseases. SMART Anti-IL-12 Antibody was humanized at PDL from a murine anti-IL-12 antibody that was licensed, together with certain intellectual property related to anti-IL-12 therapy, from Hoffmann-La Roche Inc. IL-12 is a cytokine that may have considerable potential as a target in the therapy of autoimmune diseases.
4. Indication:  Investigated for use/treatment in autoimmune diseases and inflammatory disorders (unspecified).
DrugId:  24
1. Name:  Cyclomethicone 5
2. Groups:  Approved
3. Description:  Cyclomethicone 5 is member of cyclomethicone, which are a group of liquid methyl siloxanes that have low viscosity and high volatility. Cyclomethicones are cyclic in structure with a monomer backbone of one silicon and two oxygen atoms bonded together. Cyclomethicone 5 is used in cosmetic and personal products as a skin emollient.
4. Indication:  Not Available
DrugId:  25
1. Name:  Racemethionine
2. Groups:  Approved, Experimental
3. Description:  A preparation of methionine that includes a mixture of D-methionine and L-methionine isomers.
4. Indication:  Not Available
